gamma-eudesmol: isomer of beta-eudesmol; found in plants and fungi [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
gamma-eudesmol : A eudesmane sesquiterpenoid in which the eudesmane skeleton carries a hydroxy substituent at C-11 and has a double bond between C-4 and C-5. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]
ID Source | ID |
---|---|
PubMed CID | 6432005 |
CHEMBL ID | 477900 |
CHEBI ID | 62513 |
SCHEMBL ID | 194293 |
MeSH ID | M0417651 |
Synonym |
---|
gamma-eudesmol |
.gamma.-eudesmol |
2-naphthalenemethanol, 1,2,3,4,4a,5,6,7-octahydro-.alpha.,.alpha.,4a,8-tetramethyl-, (2r-cis)- |
uncineol |
1209-71-8 |
C17124 |
machilol |
selinenol |
CHEMBL477900 |
chebi:62513 , |
2-[(2r,4ar)-4a,8-dimethyl-2,3,4,5,6,7-hexahydro-1h-naphthalen-2-yl]propan-2-ol |
2-naphthalenemethanol, 1,2,3,4,4a,5,6,7-octahydro-alpha,alpha,4a,8-tetramethyl-, (2r-cis)- |
(2r-cis)-1,2,3,4,4a,5,6,7-octahydro-alpha,alpha,4a,8-tetramethyl-2-naphthalenemethanol |
unii-c3m974g2be |
c3m974g2be , |
eudesm-4-en-11-ol |
(+)-gamma-eudesmol |
2-[(2r,4ar)-4a,8-dimethyl-1,2,3,4,4a,5,6,7-octahydronaphthalen-2-yl]propan-2-ol |
SCHEMBL194293 |
[2r-cis]-1,2,3,4,4a,5,6,7-octahydro-.alpha.,.alpha.,4a,8-tetramethyl-2-naphthalenemethanol |
2-((2r,4ar)-4a,8-dimethyl-1,2,3,4,4a,5,6,7-octahydronaphthalen-2-yl)propan-2-ol |
WMOPMQRJLLIEJV-IUODEOHRSA-N |
.gamma.-eudesmole |
Q27131974 |
DTXSID301017639 , |
2-naphthalenemethanol, 1,2,3,4,4a,5,6,7-octahydro-.alpha.,.alpha.,4a,8-tetramethyl-, (2r,4ar)- |
(2r,4ar)-1,2,3,4,4a,5,6,7-octahydro-.alpha.,.alpha.,4a,8-tetramethyl-2-naphthalenemethanol |
(+)-.gamma.-eudesmol |
eudesmol, .gamma.- |
CS-0007112 |
HY-N0065 |
2-naphthalenemethanol, 1,2,3,4,4a,5,6,7-octahydro-alpha,alpha,4a,8-tetramethyl-, (2r,4ar)- |
(2r,4ar)-1,2,3,4,4a,5,6,7-octahydro-alpha,alpha,4a,8-tetramethyl-2-naphthalenemethanol |
eudesmol, gamma- |
dtxcid001475824 |
Role | Description |
---|---|
volatile oil component | Any plant metabolite that is found naturally as a component of a volatile oil. |
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res] |
Class | Description |
---|---|
eudesmane sesquiterpenoid | Any sesquiterpenoid having a eudesmane skeleton. |
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res] |
Assay ID | Title | Year | Journal | Article |
---|---|---|---|---|
AID360352 | Cytotoxicity against human HepG2 cells by MTT assay | 2001 | Journal of natural products, May, Volume: 64, Issue:5 | Cytotoxic constituents of the fruits of Cananga odorata. |
AID360353 | Cytotoxicity against human HepG2(2.2.15) cells by MTT assay | 2001 | Journal of natural products, May, Volume: 64, Issue:5 | Cytotoxic constituents of the fruits of Cananga odorata. |
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023] |
Timeframe | Studies, This Drug (%) | All Drugs % |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (7.69) | 29.6817 |
2010's | 9 (69.23) | 24.3611 |
2020's | 3 (23.08) | 2.80 |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.
| This Compound (28.88) All Compounds (24.57) |
Publication Type | This drug (%) | All Drugs (%) |
---|---|---|
Trials | 0 (0.00%) | 5.53% |
Reviews | 0 (0.00%) | 6.00% |
Case Studies | 0 (0.00%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 13 (100.00%) | 84.16% |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |